JBIO
Price
$7.78
Change
+$0.29 (+3.87%)
Updated
Sep 4, 04:59 PM (EDT)
Capitalization
245.68M
OVID
Price
$1.28
Change
-$0.05 (-3.76%)
Updated
Sep 4, 04:59 PM (EDT)
Capitalization
94.22M
69 days until earnings call
Interact to see
Advertisement

JBIO vs OVID

Header iconJBIO vs OVID Comparison
Open Charts JBIO vs OVIDBanner chart's image
Jade Biosciences
Price$7.78
Change+$0.29 (+3.87%)
Volume$601
Capitalization245.68M
Ovid Therapeutics
Price$1.28
Change-$0.05 (-3.76%)
Volume$46.94K
Capitalization94.22M
JBIO vs OVID Comparison Chart in %
Loading...
JBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OVID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JBIO vs. OVID commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JBIO is a Hold and OVID is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (JBIO: $7.49 vs. OVID: $1.33)
Brand notoriety: JBIO and OVID are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JBIO: 34% vs. OVID: 58%
Market capitalization -- JBIO: $245.68M vs. OVID: $94.22M
JBIO [@Biotechnology] is valued at $245.68M. OVID’s [@Biotechnology] market capitalization is $94.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JBIO’s FA Score shows that 1 FA rating(s) are green whileOVID’s FA Score has 1 green FA rating(s).

  • JBIO’s FA Score: 1 green, 4 red.
  • OVID’s FA Score: 1 green, 4 red.
According to our system of comparison, both JBIO and OVID are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JBIO’s TA Score shows that 4 TA indicator(s) are bullish while OVID’s TA Score has 5 bullish TA indicator(s).

  • JBIO’s TA Score: 4 bullish, 5 bearish.
  • OVID’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, OVID is a better buy in the short-term than JBIO.

Price Growth

JBIO (@Biotechnology) experienced а -5.72% price change this week, while OVID (@Biotechnology) price change was +5.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.27%. For the same industry, the average monthly price growth was +7.08%, and the average quarterly price growth was +29.28%.

Reported Earning Dates

OVID is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+0.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JBIO($246M) has a higher market cap than OVID($94.2M). JBIO YTD gains are higher at: 182.830 vs. OVID (42.444). JBIO has more cash in the bank: 221M vs. OVID (38.3M). JBIO has less debt than OVID: JBIO (792K) vs OVID (14.1M).
JBIOOVIDJBIO / OVID
Capitalization246M94.2M261%
EBITDAN/A-41.01M-
Gain YTD182.83042.444431%
P/E RatioN/AN/A-
RevenueN/A6.65M-
Total Cash221M38.3M577%
Total Debt792K14.1M6%
FUNDAMENTALS RATINGS
OVID: Fundamental Ratings
OVID
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JBIOOVID
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 14 days ago
81%
Bullish Trend 9 days ago
75%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
JBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OVID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WVMDF1.350.15
+12.67%
West Vault Mining Inc.
TSCDF5.730.04
+0.70%
Tesco PLC
FOSUY17.50N/A
N/A
Fosun International, Ltd.
LSDAF153.61N/A
N/A
Lassonde Industries Inc.
CSRNF0.04N/A
-8.51%
Canstar Resources Inc.

JBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, JBIO has been closely correlated with OVID. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if JBIO jumps, then OVID could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JBIO
1D Price
Change %
JBIO100%
-1.64%
OVID - JBIO
79%
Closely correlated
+8.13%
KNSA - JBIO
37%
Loosely correlated
+3.50%
SYRE - JBIO
29%
Poorly correlated
+1.08%
KPRX - JBIO
29%
Poorly correlated
+2.56%
OPT - JBIO
27%
Poorly correlated
N/A
More

OVID and

Correlation & Price change

A.I.dvisor indicates that over the last year, OVID has been closely correlated with JBIO. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if OVID jumps, then JBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OVID
1D Price
Change %
OVID100%
+8.13%
JBIO - OVID
79%
Closely correlated
-1.64%
ARCT - OVID
46%
Loosely correlated
+2.93%
GBIO - OVID
44%
Loosely correlated
N/A
DNLI - OVID
42%
Loosely correlated
-0.91%
MGNX - OVID
41%
Loosely correlated
+9.77%
More